Cargando…
Regulatory affairs and biotechnology in Europe: III. Introduction into good regulatory practice — Validation of virus removal and inactivation
This paper provides for an overview on the practical consequences of the EC guideline (III/8115/89): Validation of Virus Removal and Inactivation. This guideline can only be used as a blueprint in combination with other specific guidelines, especially those concerned with EC recommendations during p...
Autor principal: | Trijzelaar, Ben |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Kluwer Academic Publishers
1993
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087717/ https://www.ncbi.nlm.nih.gov/pubmed/8398576 http://dx.doi.org/10.1007/BF01877422 |
Ejemplares similares
-
Regulatory Affairs 101: Introduction to Expedited Regulatory Pathways
por: Cox, Erica M., et al.
Publicado: (2020) -
Medical Device Apps: An Introduction to Regulatory Affairs for Developers
por: Keutzer, Lina, et al.
Publicado: (2020) -
Future directions in regulatory affairs
por: Chisholm, Orin, et al.
Publicado: (2023) -
Regulatory affairs for biomaterials and medical devices
por: Amato, Stephen F, et al.
Publicado: (2015) -
Regulatory Affairs 101: Introduction to Investigational New Drug Applications and Clinical Trial Applications
por: Chiodin, Davy, et al.
Publicado: (2019)